These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16054187)

  • 1. The core-specific precursor T cell response is directed to the N-terminal and central parts of the protein and positively correlates to the viral load in chronically HCV-infected patients.
    Janvier G; Chaix ML; Fontaine H; Bresson JL; Pol S; Riviere Y
    Virology; 2005 Sep; 340(2):318-25. PubMed ID: 16054187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses.
    Hultgren C; Desombere I; Leroux-Roels G; Quiroga JA; Carreno V; Nilsson B; Weiland O; Sällberg M
    J Hepatol; 2004 Jun; 40(6):971-8. PubMed ID: 15158338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
    Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
    Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
    Ruys TA; Nanlohy NM; van den Berg CH; Hassink E; Beld M; van de Laar T; Bruisten S; Wit F; Krol A; Prins M; Lange J; van Baarle D
    J Viral Hepat; 2008 Jun; 15(6):409-20. PubMed ID: 18221302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
    Rohrbach J; Robinson N; Harcourt G; Hammond E; Gaudieri S; Gorgievski M; Telenti A; Keiser O; Günthard HF; Hirschel B; Hoffmann M; Bernasconi E; Battegay M; Furrer H; Klenerman P; Rauch A;
    Gut; 2010 Sep; 59(9):1252-8. PubMed ID: 20660698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producing peripheral blood lymphocytes in infected humans with and without cirrhosis.
    Anthony DD; Post AB; Valdez H; Peterson DL; Murphy M; Heeger PS
    Clin Immunol; 2001 May; 99(2):232-40. PubMed ID: 11318595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
    Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
    Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
    Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
    Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic relevance of F protein in chronic hepatitis C virus infection.
    Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
    Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.
    Cerny A; Chisari FV
    Hepatology; 1999 Sep; 30(3):595-601. PubMed ID: 10462362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.
    Folgori A; Spada E; Pezzanera M; Ruggeri L; Mele A; Garbuglia AR; Perrone MP; Del Porto P; Piccolella E; Cortese R; Nicosia A; Vitelli A;
    Gut; 2006 Jul; 55(7):1012-9. PubMed ID: 16484505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ; Xie Y; Li ZQ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of T cell cross-reactivity on HCV-peptide specific human T cell response.
    Kennedy PT; Urbani S; Moses RA; Amadei B; Fisicaro P; Lloyd J; Maini MK; Dusheiko G; Ferrari C; Bertoletti A
    Hepatology; 2006 Mar; 43(3):602-11. PubMed ID: 16496333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
    Ahlenstiel G; Woitas RP; Iwan A; Nattermann J; Feldmann G; Rockstroh JK; Oldenburg J; Kupfer B; Sauerbruch T; Spengler U
    Immunol Invest; 2009; 38(1):1-13. PubMed ID: 19172482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
    Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
    Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
    van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
    J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.